Hexagon Nutrition IPO sails through at 10.98x on Day 3, retail piles in at 11.71x

The clinical nutrition maker behind Pentasure and Pediagold closed its ₹138.87 cr OFS issue 10.98x subscribed, with NII at 24.80x and retail at 11.71x. Priced at ₹42-45 with GMP of ₹6.5, the 75-country exporter lists 12 June. SBICAP and BP Equities flag a subscribe call on 14% EBITDA margins and 0.18 D/E.

— Source publishedTue, 9 Jun, 2026, 11:12 IST·First seen Tue, 9 Jun, 2026, 11:16 IST·Source Mint · Markets

What happened

Hexagon Nutrition's ₹138.87 cr OFS IPO subscribed 10.98x on day 3, with retail at 11.71x and NII at 24.80x. The clinical nutrition company behind Pentasure and

Key facts

  • 10.98x subscription day 3
  • retail 11.71x
  • NII 24.80x
  • QIB 19%
  • price band ₹42-45
  • issue size ₹138.87 cr
  • anchor ₹41.66 cr
  • GMP ₹6.5
  • 75 countries
  • EBITDA margin 14% 9MFY26
  • D/E 0.18

Why this matters

Hexagon's 12 June listing creates a new public comp for clinical and pediatric nutrition assets, potentially recalibrating private valuations across the specialty nutrition M&A landscape.